Positron emission tomography in the Rett syndrome: clinical, biochemical and pathological correlates

Brain Dev. 1992 May:14 Suppl:S75-9.

Abstract

A consistent constellation of clinical signs and symptoms define the Rett syndrome, the most prominent of which are disorders of movement and tone. Preliminary pathologic and neurochemical data indicate predominant involvement of the nigrostriatal dopaminergic pathways and the cholinergic system of the basal forebrain region. The age of onset differentiates the Rett syndrome from Alzheimer and Parkinson disease with similar lesions. PET scanning makes it possible to relate the chemistry of the brain to function by measuring the number and affinity of neuroreceptors, metabolism in specific brain regions, and provide important determinants of the underlying mechanisms in disease states.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Brain / metabolism
  • Female
  • Glucose / metabolism
  • Humans
  • Receptors, Dopamine / metabolism
  • Receptors, Dopamine D2
  • Rett Syndrome / diagnostic imaging*
  • Rett Syndrome / metabolism
  • Tomography, Emission-Computed

Substances

  • Receptors, Dopamine
  • Receptors, Dopamine D2
  • Glucose